<html>
<head>PUBMED IDs for FLT3LG</head>
<body bgcolor='#C5F0F2'><h1>FLT3LG</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19144991/'>Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML.</a> May 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19620960/'>Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.</a> September 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21941565/'>Comparison of Gene Expression in Human Embryonic Stem Cells, hESC-Derived Mesenchymal Stem Cells and Human Mesenchymal Stem Cells.</a> September 24  2011<br></body></html>
